Given the importance of IAP in regulating the response of REC and SMC to IGF-I it is reasonable to conclude that identification of compounds that can disrupt the hyperglycemia induced increase in IAP-SHPS-1 association has the potential to inhibit IGF-I signaling in vascular cells in vivo. This evidence concerns the gene CD47 and Hyperglycemia.